Colorcon expands in India
The new technical service laboratory is the company's 20th across the world.
Colorcon has opened a new technical service laboratory and conference facility in Noida, India to support continuing industry growth and extend local assistance to customers in the northern part of India. The new laboratory, which is Colorcon’s 20th across the world, is strategically located to provide convenient access for customers across the region.
According to Rajesh Parab, General Manager, Colorcon South Asia, “The northern part of India is significant for Colorcon as it’s a pharmaceutical development and manufacturing hub. This strategic investment demonstrates Colorcon’s commitment and focus to the fast-growing Indian Pharmaceutical market in this region.”
Sailesh Verma, Regional Sales Manager added: “The new laboratory in Noida, near Delhi, brings a fast response to our customers and helps them to respond to market dynamics, bringing product to market faster. The facility extends Colorcon’s direct support to customers and supplements the existing laboratory facilities established in Goa to provide a faster turnaround time for their projects and easy access to technical services.”
Shantanu Damle, Technical Manager, Coloron South Asia explained: “Being located closer to our customers (in the north), this technical centre will provide the opportunity for customers to directly visit and conduct laboratory scale coating trials using conventional and automated coating equipment that aligns with the equipment in their facilities, saving them valuable development and scale-up time.”
The facility also provides the opportunity to extend the educational events offered through the Colorcon Academy, with resources to conduct Colorcon Coating Schools and Formulation Training Programs which will facilitate knowledge sharing and benefit individuals as well as their companies.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance